BURLINGTON, Mass., June 19, 2013 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices and implants, announced today its third product launch since March. These three new products strengthen LeMaitre Vascular's position as a one-stop-shop for peripheral vascular devices:
- MultiTASC Dissection/Transection Device (launched March 27, 2013)
- 1.5mm Expandable LeMaitre Valvulotome (launched April 29, 2013)
- AlboSure Vascular Patch (launched June 18, 2013)
The MultiTASC device is a remote endarterectomy device which dissects and transects arterial plaque in a single pass, reducing procedure times and complications.
The 1.5 mm Expandable LeMaitre Valvulotome is the 7th generation of our flagship valvulotome for in situ bypass. The smaller size allows for more effective valve cutting in smaller vessels while reducing potential damage to fragile vein walls.
The AlboSure Patch is a polyester alternative to the company's XenoSure Biologic Vascular Patch. Both patch platforms are used primarily during carotid endarterectomy surgery.
"These three product launches underscore LeMaitre's commitment to R&D and our mission to be a one-stop-shop for peripheral vascular devices. Our growing sales force – now at 83 reps - is eager to bring these updated and expanded product offerings to our vascular surgeon customers," said George W. LeMaitre, Chairman and CEO.